Univercells

Univercells company information, Employees & Contact Information

Explore related pages

Related company profiles:

For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit.

Company Details

Employees
75
Founded
-
Address
Avenue Herrmann Debroux 54, Bruxelles,brussels 1160,belgium
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Bruxelles, Brussels
Looking for a particular Univercells employee's phone or email?

Univercells Questions

News

Repligen and Univercells Partner to Enable Real-Time Viral Vector and Vaccine Biomanufacturing Monitoring - Genetic Engineering and Biotechnology News

Repligen and Univercells Partner to Enable Real-Time Viral Vector and Vaccine Biomanufacturing Monitoring Genetic Engineering and Biotechnology News

Univercells Technologies unveils new controller for large-scale viral and advanced therapy manufacturing - Cleanroom Technology

Univercells Technologies unveils new controller for large-scale viral and advanced therapy manufacturing Cleanroom Technology

Quantoom, Univercells and Fiocruz ink collaboration to bolster RNA-based vaccines in Brazil and beyond - Fierce Pharma

Quantoom, Univercells and Fiocruz ink collaboration to bolster RNA-based vaccines in Brazil and beyond Fierce Pharma

Codagenix and Univercells Announce Research Collaboration on Undisclosed, High-Priority Human Vaccine Target with Global Public Health Demand - PR Newswire

Codagenix and Univercells Announce Research Collaboration on Undisclosed, High-Priority Human Vaccine Target with Global Public Health Demand PR Newswire

Donaldson buys Univercells for $148m - BioProcess Insider - BioProcess International

Donaldson buys Univercells for $148m - BioProcess Insider BioProcess International

CEPI partners with biotech Jurata Thin Film to create needle-free mRNA vaccines and improve access - CEPI

CEPI partners with biotech Jurata Thin Film to create needle-free mRNA vaccines and improve access CEPI

Pioneering Innovation for Universal Access to Biologics - Univercells’ journey with RISE with SAP - SAP News Center

Pioneering Innovation for Universal Access to Biologics - Univercells’ journey with RISE with SAP SAP News Center

Univercells, Repligen Partner to Integrate Real-Time Monitoring Capabilities - Contract Pharma

Univercells, Repligen Partner to Integrate Real-Time Monitoring Capabilities Contract Pharma

Univercells Technologies Debuts the scale-X™ Nitro Controller to Expand Access to Large-Scale Viral and Advanced Therapy Manufacturing - Business Wire

Univercells Technologies Debuts the scale-X™ Nitro Controller to Expand Access to Large-Scale Viral and Advanced Therapy Manufacturing Business Wire

Institut Pasteur de Dakar to manufacture affordable Measles and Rubella vaccine - African Media Agency

Institut Pasteur de Dakar to manufacture affordable Measles and Rubella vaccine African Media Agency

Univercells Technologies Acquired by Donaldson Company - PR Newswire

Univercells Technologies Acquired by Donaldson Company PR Newswire

UPenn, Univercells partner to enhance gene therapy production - BioProcess International

UPenn, Univercells partner to enhance gene therapy production BioProcess International

Univercells, Batavia Biosciences on tap to help bring affordable measles and rubella shots to Africa - Fierce Pharma

Univercells, Batavia Biosciences on tap to help bring affordable measles and rubella shots to Africa Fierce Pharma

Univercells Technologies and UPENN Expand Gene Therapy Partnership - Genetic Engineering and Biotechnology News

Univercells Technologies and UPENN Expand Gene Therapy Partnership Genetic Engineering and Biotechnology News

Donaldson Company, Inc., Through Its Univercells Technologies Business, Expands Their Relationship With the Gene Therapy Program at the University of Pennsylvania to Evaluate Certain Bioreactors for Scalable Gene Therapy Production - Business Wire

Donaldson Company, Inc., Through Its Univercells Technologies Business, Expands Their Relationship With the Gene Therapy Program at the University of Pennsylvania to Evaluate Certain Bioreactors for Scalable Gene Therapy Production Business Wire

Univercells buys plant, launches CDMO to service booming cell & gene sector - BioProcess International

Univercells buys plant, launches CDMO to service booming cell & gene sector BioProcess International

A Small-Footprint, Integrated, and Automated Platform for Viral Production - Genetic Engineering and Biotechnology News

A Small-Footprint, Integrated, and Automated Platform for Viral Production Genetic Engineering and Biotechnology News

Univercells to scale-up sub 30 cent polio vaccine platform - BioProcess International

Univercells to scale-up sub 30 cent polio vaccine platform BioProcess International

Altamira teams with Univercells on nanoparticle-delivered mRNA vaccines - BioProcess International

Altamira teams with Univercells on nanoparticle-delivered mRNA vaccines BioProcess International

Univercells Technologies teams with High Purity New England for distribution - BioProcess International

Univercells Technologies teams with High Purity New England for distribution BioProcess International

Univercells' CDMO Exothera hopes to help scale COVID-19 vaccine manufacturing - Fierce Pharma

Univercells' CDMO Exothera hopes to help scale COVID-19 vaccine manufacturing Fierce Pharma

KKR-backed Univercells Technologies acquired by Donaldson Company - pehub.com

KKR-backed Univercells Technologies acquired by Donaldson Company pehub.com

Donaldson Acquires Belgian Univercells Technologies for €138m - European Biotechnology Magazine

Donaldson Acquires Belgian Univercells Technologies for €138m European Biotechnology Magazine

Univercells SA raises €44m in first close of its Series D - European Biotechnology Magazine

Univercells SA raises €44m in first close of its Series D European Biotechnology Magazine

Univercells inks deal to produce prefabricated vaccine facilities for potential COVID-19 shot - Fierce Pharma

Univercells inks deal to produce prefabricated vaccine facilities for potential COVID-19 shot Fierce Pharma

KKR pumps €50m into Univercells through Gamma funding platform - BioProcess International

KKR pumps €50m into Univercells through Gamma funding platform BioProcess International

Univercells Introduces NevoLine Upstream Platform - Contract Pharma

Univercells Introduces NevoLine Upstream Platform Contract Pharma

A Brief History of Adherent Cell Culture: Where We Come From and Where We Should Go - BioProcess International

A Brief History of Adherent Cell Culture: Where We Come From and Where We Should Go BioProcess International

Top Univercells Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant